Kenneth M. Daly

Kenneth Daly focuses his practice on personal injury and mass tort litigation, including lawsuits involving dangerous pharmaceutical drugs. Kenneth is significantly involved in the Depakote (valproic acid) Products Liability Litigation. Additionally, Kenneth represents clients in a variety of personal injury claims.

Since starting at Burg Simpson in 2009, Kenneth earned his Bachelor of Arts from Ohio University, graduating magna cum laude in 2012 and earned his Juris Doctorate from the University of Cincinnati College of Law in 2015. Kenneth is currently admitted to practice in Ohio and Kentucky.

Honors & Accolades

The National Trial Lawyers Top 40 Under 40, 2019-2020

Publications & Media

Daly, Kenneth M. Burg Simpson Files Complaint Against Endologix For Failed AFX AAA Device. www.burgsimpson.com, May 10, 2019

Daly, Kenneth M. U.S. Food & Drug Administration Issues Warning to Company for Marketing Dangerous Unapproved Stem Cell Products. www.burgsimpson.com, December 31, 2018